ONI
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $75M
Investors
- 6
About ONI
a. ONI Bio, is a biotech company specializing in super-resolution microscopy, which allows researchers to zoom in on molecules and structures within living cells. The company offers a cloud-based software platform called CODI (Collaborative Discovery) that provides researchers with the possibility of sharing datasets with different degrees of privacy, enabling others to not only visualize datasets but also how they have been processed to reach scientific conclusions. ONI Bio also offers an EV Profiling App on CODI that can quantify size and biomarker distributions from a collection of single extracellular vesicles (EVs), with a range of tools from drift correction, single-molecule filtering, clustering, cluster filtering, and counting of biomarker distribution. ONI Bio has published over 200 papers with their products.
Who invested in ONI
6 investors across 1 round
See all investors in ONI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 20, 2022
Amount
$75M
Investors
Questions about ONI
Who invested in ONI?
ONI has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ONI raised?
ONI has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ONI last raise money?
ONI's most recent round on record is a Series B, in Jan 2022.
What does ONI do?
ONI is a healthcare it company.
Where is ONI headquartered?
ONI is headquartered in Oxford, UK.
Which VCs invest in companies like ONI?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back healthcare it companies at ONI's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like ONI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.